Sana Biotechnology Inc (SANA)

Apr 19, 2025, 8:10 AM EDT - 4 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Apr 10, 2025, 5:45 AM EDT - 13 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANA

Apr 9, 2025, 11:40 AM EDT - 14 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Mar 24, 2025, 11:45 PM EDT - 4 weeks ago

Sana Biotechnology: High-Risk High-Reward With Breakthrough UP421

Mar 17, 2025, 4:05 PM EDT - 5 weeks ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Feb 24, 2025, 4:05 PM EST - 2 months ago

Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference

Jan 8, 2025, 4:05 PM EST - 3 months ago

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 10:30 AM EST - 3 months ago

Sana Biotechnology: Stock Price Rise Deserved Post Diabetes Cell Therapy Success

Jan 8, 2025, 9:27 AM EST - 3 months ago

Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why

Jan 8, 2025, 7:25 AM EST - 3 months ago

This Biotech Stock Just Soared 240%. Why It Can Go Higher.

Jan 7, 2025, 4:05 PM EST - 3 months ago

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Dec 4, 2024, 3:36 PM EST - 5 months ago

Sana: Major Inflection Point For SC291 In 2025 Targeting Lupus

Nov 25, 2024, 4:05 PM EST - 5 months ago

Sana Biotechnology to Present at December 2024 Investor Conferences

Nov 19, 2024, 5:31 PM EST - 5 months ago

Sana Biotechnology: The Story Becomes Murkier

Nov 8, 2024, 9:00 AM EST - 5 months ago

Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates

Nov 4, 2024, 4:30 PM EST - 6 months ago

Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025

Sep 30, 2024, 4:05 PM EDT - 7 months ago

Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference

Aug 29, 2024, 4:05 PM EDT - 8 months ago

Sana Biotechnology to Present at September 2024 Investor Conferences

Aug 26, 2024, 4:05 PM EDT - 8 months ago

Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer

Aug 2, 2024, 7:12 PM EDT - 9 months ago

Sana Biotechnology cuts the ribbon at new manufacturing facility near Seattle

May 6, 2024, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at May and June 2024 Investor Conferences

Apr 21, 2024, 9:02 PM EDT - 1 year ago

Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX

RXRX VKTX

Feb 29, 2024, 4:05 PM EST - 1 year ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

Feb 28, 2024, 4:05 PM EST - 1 year ago

Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference

Feb 13, 2024, 4:05 PM EST - 1 year ago

Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP